APA (7th ed.) Citation

Dong, W., Lei, P., Liu, X., Li, Q., & Cheng, X. (2021). Case Report: Complete Response to Nivolumab in a Patient With Programmed Cell Death 1 Ligand 1-Positive and Multiple Gene-Driven Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Dong, Wen, Pengfei Lei, Xin Liu, Qin Li, and Xiangyang Cheng. Case Report: Complete Response to Nivolumab in a Patient With Programmed Cell Death 1 Ligand 1-Positive and Multiple Gene-Driven Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma. Frontiers Media S.A, 2021.

MLA (8th ed.) Citation

Dong, Wen, et al. Case Report: Complete Response to Nivolumab in a Patient With Programmed Cell Death 1 Ligand 1-Positive and Multiple Gene-Driven Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma. Frontiers Media S.A, 2021.